Haven Hospice Foundation Honors the Memory of Longtime Supporter and Leader Danny Martinez

PALATKA, Fla., Oct. 10, 2023 /PRNewswire/ — The Haven Hospice Foundation joins the Palatka community in mourning the passing of longtime supporter and business leader Danny Martinez. Mr. Martinez served the Palatka community with distinction for decades. “As a member of the Haven Hospice Community Advisory Board and as chairman of the Haven Hospice Foundation … Read more

Industry Expert Andrea Shultz Joins CrossMed Healthcare as CFO

OMAHA, Neb., Oct. 9, 2023 /PRNewswire/ — CrossMed Healthcare Staffing Solutions is excited to welcome Andrea Schultz to the team as Chief Financial Officer. Shultz brings over a decade of leadership experience in healthcare staffing and provides a variety of expertise cross-divisionally. She began her career in healthcare staffing as HR/Payroll Manager, then, with rapid … Read more

Innovent Announces First Patient Dosed in the Phase 3 Clinical Study (STAR) of Efdamrofusp Alfa (IBI302), a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Neovascular Age-related Macular Degeneration USA – English APAC – English

ROCKVILLE, Md. and SUZHOU, China, Oct. 8, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the first patient with neovascular age-related macular degeneration (nAMD) has been successfully dosed in … Read more

Cano Health Files Preliminary Proxy Statement with the SEC to initiate plan for Reverse Stock Split

MIAMI, Oct. 5, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or the “Company“) (NYSE: CANO) today announced that it has filed a preliminary proxy statement with the SEC regarding a special stockholders’ meeting to authorize Cano Health’s Board of Directors to effect a reverse stock split of the Company’s Class A and Class B common … Read more

US-AMERIKANISCHE FDA ERTEILT LIPOGEMS® ZWEITE IDE-ZULASSUNG FÜR EINE KLINISCHE STUDIE ZUR BEHANDLUNG VON KNIE-OSTEOARTHRITIS

ATLANTA, 5. Okt. 2023 /PRNewswire/ — Die US Food and Drug Administration (FDA) hat Lipogems eine weitere IDE-Studie (Investigational Device Exemption) für die Verwendung von Mikrofett zur Behandlung von Knie-Osteoarthritis (OA) erteilt. Die zweite IDE-Studie wird die Sicherheit und Wirksamkeit bei der Behandlung von Knie-OA im Vergleich zur Behandlung mit Kochsalzlösung untersuchen und 15-20 angesehene akademische … Read more

Light Therapy Market to grow by USD 246.87 million from 2022 to 2027 | North America to account for 43% of market growth

NEW YORK, Oct. 4, 2023 /PRNewswire/ — The light therapy market is expected to grow by USD 246.87 million from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 4.72% during the forecast period, according to Technavio Research. The market has been segmented by end-user (commercial, domestic, and healthcare), type … Read more

Firmament Facilitates Merger of Prime Providers and Right Choice In-Home Care

NEW YORK, Oct. 3, 2023 /PRNewswire/ — Firmament, a provider of structured equity and debt capital solutions to small- and medium-sized enterprises, announced today an investment in Prime Providers (“Prime” or the “Company”), to support the Company’s acquisition of Right Choice In-Home Care (“Right Choice”). Prime is a home-based healthcare organization providing private duty nursing, … Read more

Vela Diagnostics colabora con SRL Inc. para la distribución de productos en Japón

FAIRFIELD, N.J., 2 de octubre de 2023 /PRNewswire/ — Vela Diagnostics anunció hoy una colaboración de investigación con SRL Inc, una importante empresa japonesa de servicios de atención médica. Esta asociación tiene como objetivo facilitar la distribución de las soluciones de diagnóstico molecular de vanguardia de Vela Diagnostics en Japón. Establecida en 1970, SRL Inc … Read more

Leo Cancer Care et THERYQ collaborent sur le positionnement patient innovant du système FLASHDEEP

PEYNIER, France, 1er octobre 2023 /PRNewswire/ — La collaboration entre Leo Cancer Care et THERYQ réunit la vaste expertise des deux organisations pour créer une solution intégrée qui promet de révolutionner le traitement des tumeurs solides profondes. S’appuyant sur une technologie de pointe et une ingénierie de précision, cette collaboration vise à fournir aux radio-oncologues et … Read more

SIBIONICS to Make Debut at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)

SHENZHEN, China, Sept. 30, 2023 /PRNewswire/ — The 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from October 2nd to 6th, 2023, in Hamburg, Germany. Making its debut at this prestigious event, Shenzhen Sibionics Technology Co., Ltd. (hereinafter referred to as “SIBIONICS”) will unveil its flagship … Read more